Collagen Solutions PLC (LON:COS) has unveiled its third consecutive half of double-digit revenue growth.
Sales in the six months ended September 30 were up 14.4% to £2.23mln, the company said in a trading statement.
WATCH: Full interview: Collagen Solutions released financial number showing more strong sales numbers
The manufacturer of biomaterials used in regenerative medicines said it won four new customer contracts and 10 new customers in the period.
Its progress has been provided added momentum by a June fundraiser, which brought in almost £6mln before fees.
Chief executive Jamal Rushdy said: "We are pleased to report the third consecutive six-month period of double-digit sales growth demonstrating consistent performance to our expectations by the Collagen Solutions global team.
“Our core business remains strong and our initiative to increase capacity is on track to meet the anticipated higher demand for both collagen and tissue products."
In the update, the group said it remains in talks with the regulatory authorities as it bids to gain European health and safety sign-off in the form of a CE Mark for its ChondroMimetic cartilage repair technology.